TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Bio Farma exports new polio vaccine to Africa
The product, which was certified by the World Health Organization (WHO) last month, was exported to Angola to prevent the spread of wild poliovirus type 2 in the country.
Change Size
Workers arrange vials of vaccines at state-owned pharmaceutical company Bio Farma's headquarters in Bandung, West Java, in this file photo. (Antara/Raisan Al Farisi)
S
tate-owned pharmaceutical company PT Bio Farma exported 3.4 million vials of its new product, monovalent Oral Polio Vaccine type 2 (mOPV2), to Angola on Tuesday.
The product, which was certified by the World Health Organization (WHO) last month, was exported to Angola to prevent the spread of wild poliovirus type 2 in the country.
The production of mOPV2 was based on a request placed by the United Nations Children's Fund (UNICEF), the Global Polio Eradication Initiative (GPEI) and WHO in August 2018 to anticipate a global polio outbreak.
“Bio Farma gained the UNICEF’s trust last June for stockpiling 60 million vials of the vaccine,” Bio Farma’s marketing director Sri Harsi Teteki said during the product’s shipment in Bandung, West Java, on Tuesday.
The vaccine’s shipment to various destinations would be managed by UNICEF, she said.
The first 3.4 million doses were shipped to Angola as a finished product.
The appointment of Bio Farma as the sole mOPV2 producer, according to Bio Farma’s production director Juliman, is a testament to the world’s trust in the company.
Indonesia Food and Drug Monitoring Agency’s drug, narcotics, psychotropic and precursor production monitoring director Rita Endang said the agency would encourage Bio Farma and other pharmaceutical companies in Indonesia to continue exporting their products.
